{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:11:13Z","timestamp":1792131073210,"version":"4.4.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background and objective:<\/jats:bold> Cancer is a life-threatening disease worldwide and current standard therapy cannot fulfill all clinical needs. Chinese herbal injections have been widely used for cancer in Chinese and Western hospitals in China. This study aimed to apply evidence mapping in order to provide an overview of the clinical application of Chinese herbal injections in cancer care based on randomized controlled trials, systematic reviews, and meta-analyses.<\/jats:p><jats:p><jats:bold>Methods and results:<\/jats:bold> Seven databases were systematically searched for eligible randomized controlled trials, systematic reviews, and meta-analyses for ten Chinese herbal injections used in cancer treatment and covered in the Chinese national essential health insurance program. Excel 2016 and RStudio were used to integrate and process the data.<\/jats:p><jats:p>In total 366 randomized controlled trials and 48 systematic reviews and meta-analyses were included in the evidence mapping of herbal medicines including; Compound Kushen, Shenqi Fuzheng, Aidi, Kangai, Kanglaite, Xiaoaiping, Cinobufacin, <jats:italic>Brucea javanica<\/jats:italic> oil emulsion, <jats:italic>Polyporus<\/jats:italic> polysaccharide injection, and <jats:italic>Astragalus<\/jats:italic> polysaccharide for injection. Health insurance restricts the scope of clinical application for these herbal injections. The numbers of studies published increased, especially around 2013\u20132015. The most studied cancer types were lung cancer (118, 32.2%), colorectal cancer (39, 10.7%), and gastric cancer (39, 10.7%), and the most used injections were Compound Kushen (78, 21.3%), Shenqi Fuzheng (76, 20.8%), and Aidi (63, 17.2%). The most consistently reported benefits were observed for Compound Kushen, Shenqi Fuzheng, Aidi, and Kangai for tumor response, quality of life, myelosuppression, and enhancing immunity.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The current evidence mapping provides an overview of the outcomes and effects of Chinese herbal injections used in cancer care, and offers information on their clinical application which warrants further evidence-based research in order to inform clinical and policy decision-making.<\/jats:p>","DOI":"10.3389\/fphar.2021.666368","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T10:17:18Z","timestamp":1620382638000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Clinical Application of Chinese Herbal Injection for Cancer Care: Evidence-Mapping of the Systematic Reviews, Meta-analyses, and Randomized Controlled Trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Ming","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-jia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo-duo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-na","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-xiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"B7","unstructured":"Notice on Printing and Distributing the First Batch of National Key Monitoring Rational Drug Use List (Chemical Drugs and Biological Products)2019"},{"key":"B3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3322\/caac.21397","article-title":"Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies during and after Breast Cancer Treatment","volume":"67","author":"Greenlee","year":"2017","journal-title":"CA: a Cancer J. clinicians"},{"key":"B10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's Tool for Assessing Risk of Bias in Randomised Trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1534735411423920","article-title":"How Many Cancer Patients Use Complementary and Alternative Medicine","volume":"11","author":"Horneber","year":"2012","journal-title":"Integr. Cancer Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1200\/edbk_159514","article-title":"Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events with the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"36","author":"Kluetz","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. book Am. Soc. Clin. Oncol. Annu. Meet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.fitote.2018.07.009","article-title":"Traditional Chinese Herbal Injection: Current Status and Future Perspectives","volume":"129","author":"Li","year":"2018","journal-title":"Fitoterapia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13643-016-0204-x","article-title":"What Is an Evidence Map? A Systematic Review of Published Evidence Maps and Their Definitions, Methods, and Products","volume":"5","author":"Miake-Lye","year":"2016","journal-title":"Syst. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/acm.2018.0282","article-title":"Massage for Pain: An Evidence Map","volume":"25","author":"Miake-Lye","year":"2019","journal-title":"J. Altern. Complement. Med."},{"key":"B6","unstructured":"Notice on the Management of Clinical Application of Adjuvant Drugs: National Health Commission of the People's Republic of China2018"},{"key":"B12","unstructured":"Notice of the Ministry of Human Resources and Social Security of the State Medical Insurance Bureau on Printing and Distributing the Drug Catalogue of National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance2019"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.11842\/wst.2018.10.001","article-title":"Strategy and Path of Precision and Evidence-Based Medicine Promoting the Rational and Legal Application of Traditional Chinese Medicine Injection","volume":"20","author":"Rui Zheng","year":"2018","journal-title":"World Sci. Technology\/Modernization Traditional Chin. Med. Materia Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a Critical Appraisal Tool for Systematic Reviews that Include Randomised or Non-randomised Studies of Healthcare Interventions, or Both","volume":"358","author":"Shea","year":"2017","journal-title":"Bmj"},{"key":"B15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13643-016-0300-y","article-title":"An Evidence Map of the Effect of Tai Chi on Health Outcomes","volume":"5","author":"Solloway","year":"2016","journal-title":"Syst. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.critrevonc.2010.01.015","article-title":"Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That Is the Question","volume":"77","author":"Terret","year":"2011","journal-title":"Crit. Rev. oncology\/hematology"},{"key":"B1","unstructured":"Latest Global Cancer Data: Cancer Burden Rises to 19.3 Million New Cases and 10.0 Million Cancer Deaths in 20202020"},{"key":"B17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5582\/bst.2018.01144","article-title":"An Update on Chinese Herbal Medicines as Adjuvant Treatment of Anticancer Therapeutics","volume":"12","author":"Wang","year":"2018","journal-title":"Bst"},{"key":"B18","doi-asserted-by":"publisher","first-page":"152767","DOI":"10.1016\/j.phymed.2018.11.027","article-title":"Therapeutic Effect of Angelica and its Compound Formulas for Hypertension and the Complications: Evidence Mapping","volume":"59","author":"Wei","year":"2019","journal-title":"Phytomedicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"lgx015","DOI":"10.1093\/jncimonographs\/lgx015","article-title":"Association Between Use of Traditional Chinese Medicine Herbal Therapy and Survival Outcomes in Patients with Stage II and III Colorectal Cancer: A Multicenter Prospective Cohort Study","volume":"2017","author":"Xu","year":"2017","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ptr.6033","article-title":"Herb-Drug Interactions in Cancer Care","volume":"32","author":"Yeung","year":"2018","journal-title":"Oncology (Williston Park, NY)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3389\/fphar.2018.01470","article-title":"The Optimal Chinese Herbal Injections for Use with Radiotherapy to Treat Esophageal Cancer: A Systematic Review and Bayesian Network Meta-Analysis","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-020-3265-6","article-title":"Kang-ai Injection (\u5eb7\u827e\u6ce8\u5c04\u6db2) Inhibits Gastric Cancer Cells Proliferation through IL-6\/STAT3 Pathway","author":"Zheng","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.biopha.2019.01.042","article-title":"ShenQi FuZheng Injection Ameliorates Fatigue-like Behavior in Mouse Models of Cancer-Related Fatigue","volume":"111","author":"Zhu","year":"2019","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.666368\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T10:17:27Z","timestamp":1620382647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.666368\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":22,"alternative-id":["10.3389\/fphar.2021.666368"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.666368","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"article-number":"666368"}}